Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo, M.; Álvarez, R.; Gallego, J.; Guillen_Ponce, C.; Laquente, B.; Macarulla, T.; Muñoz, A.; Salgado Fernández, Mercedes; Vera, R.; Adeva, J.; Alés, I.; Arévalo, S.; Blázquez, J.; Calsina, A.; Carmona, A.; de Madaria, E.; Díaz, R.; Díez, L.; Fernández, T.; de Paredes, B. G.; Gallardo Martín, Maria Elena; González, I.; Hernando, O.; Jiménez, P.; Lópèz, A.; López, C.; López-Ríos, F.; Martín, E.; Martínez, J.; Martínez, A.; Montans, J.; Pazo, R.; Plaza, J. C.; Peiró, I.; Reina, J. J.; Sanjuanbenito, A.; Yaya, R.; Carrato, Alfredo
Identificadores
Identificadores
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
2017-06Título da revista
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Tipo de contido
Artigo
DeCS
neoplasias pancreáticas | oncología médica | guíaMeSH
Guideline | Pancreatic Neoplasms | Medical OncologyResumo
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
O ítem ten asociados os seguintes ficheiros de licenza: